Summary
A new practicable and precise functional protein C evaluation test is based on the activation of protein C by a snake venom activator and determination of PC activity by its property to prolong the aPTT in a clotting assay (VK=1.9% and 4% for intra- and interassay variance respectively). In 40 healthy controls there was a good correlation (r=0.74) between the functional and immunological (ELISA) evaluation. In 123 patients with both evaluation methods but more pronounced with the measurement of the protein C activity a significant protein C deficiency was found in the patient groups with disseminated solid tumors, inflammatory diseases and myocardial infarction. Besides detection of hereditary PC deficiency Type II (generation of functionally abnormal PC) the functional assay profits by recording PC inhibitor complexes and otherwise dysfunctional PC in DIC. Thus, in patients with hematological neoplasias, only protein C activity was significantly decreases. Decrease of PC activity was more pronounced compared to PC Ag in liver disease indicating synthesis of functionally deficient PC, and in oral anticoagulant treatment due to detection of PIVKA-PC.
Similar content being viewed by others
Abbreviations
- DIC:
-
Disseminierte intravaskuläre Gerinnung
- ELISA:
-
enzyme linked immunosorbant assay
- HWZ:
-
Halbwertszeit
- PC:
-
Protein C
- PCD:
-
Protein C Differenz
- PC Ag:
-
Protein C Antigen
- PC Akt:
-
Protein C Aktivität
- PCI:
-
Protein C-Inhibitor
- PIVKA:
-
Protein induced by vitamin K absence
- PTT:
-
partielle Thromboplastinzeit
- 95% VB:
-
95% Vertrauensbereich
- VK:
-
Variationskoeffizient
Literatur
Bertina RM, Broekmans AW, Krommenhoek-van Es C, van Wijngaarden A (1984) The Use of a Functional and Immunologic Assay for Plasma Protein C in the Study of the Heterogeneity of Congenital Protein C Deficiency. Thromb Haemostas 51:1–5
Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu MJ (1984) A New Method for the Estimation of Protein C by ELISA. Thromb Res 36:579–589
Comp PC, Esmon CT (1981) Generation of Fibrinolytic Activity by Infusion of Activated Protein C into Dogs. J Clin Invest 68:1221–1228
Comp PC, Nixon RR, Esmon CT (1984) Determination of Functional Levels of Protein C, an Antithrombotic Protein, Using Thrombin-Thrombomodulin Complex. Blood 63:15–21
Francis RB, Patch MJ (1983) A Functional Assay for Protein C in Human Plasma. Thromb Res 32:605–613
Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ (1981) Deficiency of Protein C in Congenital Thrombotic Disease. J Clin Invest 68:1370–1373
Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ (1982) Protein C, an Antithrombotic Protein, is Reduced in Hospitalized Patients With Intravascular Coagulation. Blood 60:261–264
Kisiel W (1979) Human Plasma Protein C. Isolation, Characterization, and Mechanism of Activation by alpha-Thrombin. J Clin Invest 64:761–769
Loebermann H, Kolde H-J, Deubel R, Peter R, Tourte E, Becker U (1986) Determination of Protein C in Plasma. Behring Inst Mitt 79:112–120
Mannucci PM, Vigano S (1982) Deficiencies of Protein C, an Inhibitor of Blood Coagulation. Lancet 2:463–466
Marlar RA, Endres-Brooks J, Miller CH (1985) Serial Studies of Protein C and its Plasma Inhibitor in Patients with Disseminated Intravascular Coagulation. Blood 66:59–63
Müller-Berghaus G, Thiel W, Preissner KT, Oehler G (1985) Protein C Activity and Concentration in Patients with Thromboembolic Disease and in Patients treated with Phenprocoumon. In: WITT I (Eds) Protein C — Biochemical and Medical Aspects. Walter de Gruyter, Berlin — New York, pp 169–176
Oehler G, Büdinger M, Heinrich D, Schöndorf T (1984) Antithrombin III-Veränderungen nach Herzinfarkt. Klin Wochenschr 62:832–836
Pabinger I (1986) Clinical Relevance of Protein C. Blut 53:63–75
Peuscher FW, Cleton FJ, Armstrong L, Stoepman-van Dalen EA van Mourik JA, van Akten WG (1980) Significance of Plasma Fibrinopeptide A (fpA) in Patients with Malignancy. J Lab Clin Med 96:5–14
Rodeghiero F, Mannucci PM, Vigano S, Barbui T, Gugliotta L, Cortellaro M, Dini E (1984) Liver Dysfunction Rather Than Intravascular Coagulation as the Main Cause of Low Protein C and Antithrombin III in Acute Leukemia. Blood 63:965–969
Sala N, Owen WG, Collen D (1984) A Functional Assay of Protein C in Human Plasma. Blood 63:671–675
Stenflo J (1976) A New Vitamin K-dependent Protein. Purification from Bovine Plasma and Preliminary Characterization. J Biol Chem 251:355–363
Stocker K, Fischer H, Meier J, Brogli M, Svendsen L (1986) Protein C Activators in Snake Venoms. Behring Inst Mitt 79:37–47
Tripodi A, Valsecchi C, Bottasso B, Sharon C, Mannucci PM, Bianchi A (1985) Comparison of a Functional Assay for Protein C with two Immunoassays. Thromb Res 40:243–248
Vigano S, Mannucci PM, D'Angelo A, Gelfi C, Gensini GF, Rostagno C, Neri Serneri GG (1984) Protein C Antigen is not an Acute Phase Reactant and is often High in Ischemic Heart Disease and Diabetes. Thromb Haemostas 52:263–266
Vigano S, Mannucci PM, Stefano S, Bottasso B, Mariani G (1984) Decrease in Protein C Antigen and Formation of an Abnormal Protein Soon after Starting Oral Anticoagulant Therapy. Brit J Haematol 57:213–220
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zurborn, K.H., Broers, H., Kirch, W. et al. Die immunologische und funktionelle Protein C-Bestimmung bei verschiedenen internistischen Erkrankungen. Klin Wochenschr 65, 906–911 (1987). https://doi.org/10.1007/BF01745501
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01745501